Please login to the form below
heart failure
This page shows the latest heart failure news and features for those working in and with pharma, biotech and healthcare.
Novartis’ heart failure drug Entresto proves superior to enalapril
Entresto is currently approved in Europe for the treatment of symptomatic chronic heart failure with reduced ejection fraction. ... In the US it is indicated for the treatment of heart failure in patients with systolic dysfunction.
Latest news
-
Moderna files record $500m IPO for RNA pipeline
AstraZeneca-partnered VEGF drug AZD8601 is currently heading the pipeline and is in phase 2 for heart failure, and following after are phase 1-stage vaccines for solid tumours and lymphoma,
-
AZ says target of $45bn sales by 2023 still achievable
The study showed Farxiga cut hospitalisations for heart failure and cardiovascular death in a broad patient population, although it missed a secondary endpoint on major adverse cardiovascular events (MACE). ... It will be followed by additional studies
-
Lilly trumpets Trulicity heart data in face-off with Novo Nordisk
cardiovascular disease, says Lilly, as less than a third (31%) of patients had established heart disease at enrolment. ... Meanwhile Boehringer and Lilly also have new real-world data for Jardiance from a patient registry, showing that the drug was able
-
NICE says no to AZ and Vifor’s rival hyperkalaemia drugs
Most common in patients with poor kidney function, heart failure or liver disease, hyperkalemia can be fatal, and patients have had few options for treatment until now. ... Hyperkalaemia is also seen in patients taking common medications for heart failure
-
Novartis buys cancer specialist Endocyte for $2.1bn
psoriasis drug Cosentyx (secukinumab) and Entresto (sacubitril/valsartan) for heart failure – up 37% to $750m and 113% to $271m, respectively – as well as Sandoz’biosimilar drugs.
More from news
Approximately 35 fully matching, plus 231 partially matching documents found.
Latest Intelligence
-
No incentive for a cure
Type 1 diabetes, heart failure, HIV - all examples of diseases that have transitioned from fatal conditions to chronic diseases, thanks to the progress in modern medicine.
-
Can value-based healthcare take off and reach for the skies?
costs. It was then backed with a ‘no response-no payment’contract. It has also struck novel reimbursement packages with its heart failure therapy Entresto and its psoriasis treatment Cosentyx.
-
Deal Watch February 2017
Sale of Priority Review Voucher (PRV). 125. Cytokinetics/ Royalty Pharma. 4.5% royalty on global sales of omecamtiv mecarbil for heart failure (phase III).
-
Deal Watch January 2017
1, 700. Ionis | Akcea. Novartis. Exclusive option to licence. AKCEA-APOCIII-LRx for heart failure.
-
A healthy challenge
All told, 50 million people in the EU are afflicted by conditions such as diabetes, congestive heart failure, chronic obstructive pulmonary disease and asthma, and in 2013 more than 1.2m
More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.
Latest appointments
-
uniQure appoints chief executive officer
for congestive heart failure and Huntington's disease into the clinic.”.
-
Cardio3 BioSciences appoints Warren Sherman chief medical officer
Sherman has over 30 years' cardiology experience, with a focus on cell-based therapies for treating patients post-myocardial infarction and with heart failure.
-
Acorda appoints new CFO
pain and heart failure.
-
Cardioxyl appoints Novartis scientist as chief medical officer
Dr Foo was responsible for the establishment and execution of multiple programmes in heart failure and the cardiorenal space at Novartis and will use her experience to lead research at ... Her unique combination of both early- and late-stage
-
CytomX makes senior changes following Pfizer deal
Prior to this period at Affymax, Dr Polu was executive director, global development at Amgen, where he worked in the development of products in nephrology, diabetes and heart failure.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Cardiac Rhythm Management Market Trends Estimates High Demand by 2015-2025
The risk factors of heart disease includes elevated cholesterol levels, diabetes mellitus, cigarette smoking, obesity and hypertension. ... Cardiac rhythm management market is the established segment of cardiology devices market, used majorly in the
-
Case Study: Qualitative research with payers in low and middle income countries
Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Senior Medical Writer
-
Great salary and benefits
-
Associate Medical Director
-
Highly Competitive
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Account Manager
-
Negotiable
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Medical Writers
-
Competitive Salary and Benefits
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Account Director
-
Excellent benefits
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
Senior Medical Writer
-
Competitive Salary
- Senior Systematic Review Analyst - Oxford
-
Negotiable
-
Account Director
-
£48, 000 - £60, 000
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
Subscribe to our email news alerts
- Bioimpedance Device Market Revenue, Opportunity, Forecast and Value Chain 2017 - 2027
- Osteotomy Plates Market Volume Forecast and Value Chain Analysis 2017 - 2027
- Audiology Services Market size and Key Trends in terms of volume and value 2017 - 2027
- Reverse Transcriptase Enzymes Market Dynamics, Forecast, Analysis and Supply Demand 2017 - 2027
- Bedless Hospitals Market Analysis, Segments, Growth and Value Chain 2017 - 2027
- Beta Thalassemia Testing Market Report Explored in Latest Research 2016-2026
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Quick links
Infographics
